Hwang et al. found that out of the 180 enzyme inhibitors they tested, the calmodulin antagonist fluphenazine-N-2-chloroethane alone enhanced caspase-8 activity in human lung cancer H1299 cells and, furthermore, inhibited binding between calmodulin and cFLIP [8]. Here, CFLAR is linked to lung cancer.